NL-OMON34092
Completed
Phase 4
PE-Prove Study PROMUS* Element* Everolimus-Eluting Coronary Stent System European Post-Approval Surveillance Study A prospective, open label, multi-center observational study - PE-Prove study
Boston Scientific International S.A.0 sites90 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Boston Scientific International S.A.
- Enrollment
- 90
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients who are candidates for Coronary artery stenting, signed the Informed Consent Form and are eligible to receive a PROMUS\* Element\* stent will be evaluated for enrollment in this study.
Exclusion Criteria
- •No study\-specific exclusion criteria apart from any contra\-indications
- •Page 20\-21 protocol
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Study examining the PROMUS Element everolimus-eluting stent in multi-center Coronary Intervention of complex Arterial Lesion Subsets (OCT and IVUS sub analysis)Complex coronary artery diseaseJPRN-UMIN000021122The PCI Guideline Research Society50
Not yet recruiting
Not Applicable
Study examining the PROMUS Element everolimus-eluting stent in multi-center Coronary Intervention of complex Arterial Lesion SubsetsJPRN-UMIN000008651The PCI Guideline Research Society800
Unknown
Not Applicable
Study Examining the PROMUS Element Everolimus-eluting Stent in Multi-center Coronary Intervention of Complex Arterial Lesion SubsetsCoronary Artery DiseaseNCT01670318The PCI Guideline Research Society800
Completed
Phase 3
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL)Coronary Artery DiseaseNCT01500434Boston Scientific Corporation102
Completed
Not Applicable
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small VesselsCoronary Artery DiseaseNCT01498692Boston Scientific Corporation94